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ABSTRACT - Background: Asthma, laryngitis and chronic cough are atypical symptoms of 
the gastroesophageal reflux disease. Aim: To analyze the efficacy of laparoscopic surgery 
in the remission of extra-esophageal symptoms in patients with gastroesophageal reflux, 
related to asthma. Methods: Were reviewed the medical records of 400 patients with 
gastroesophageal reflux disease submitted to laparoscopic Nissen fundoplication from 1994 
to 2006, and identified 30 patients with extra-esophageal symptoms related to asthma. The 
variables considered were: gender, age, gastroesophageal symptoms (heartburn, acid reflux 
and dysphagia), time of reflux disease, treatment with proton pump inhibitor, use of specific 
medications, treatment and evolution, number of attacks and degree of esophagitis. Data were 
subjected to statistical analysis, comparing the pre- and post-surgical findings. Results: The 
comparative analysis before surgery (T1) and six months after surgery (T2) showed a significant 
reduction on heartburn and reflux symptoms. Apart from that, there was a significant difference 
between the patients with daily crises of asthma (T1 versus T2,  45.83% to 16.67%, p=0.0002) 
and continuous crises (T1, 41.67% versus T2, 8.33%, p=0.0002). Conclusion: Laparoscopic 
Nissen fundoplication was effective in improving symptoms that are typical of reflux disease 
and clinical manifestations of asthma. 
RESUMO - Racional: A asma, a laringite e a tosse crônica são sintomas atípicos da doença do 
refluxo gastroesofágico. Objetivo: Analisar a eficácia da cirurgia laparoscópica na remissão 
de sintomas extra-esofágicos em doentes com refluxo gastroesofágico, relacionada com 
a asma. Métodos: Foram revisados  os prontuários de 400 doentes com doença do refluxo 
gastroesofágico submetidos à fundoplicatura a Nissen entre 1994 e 2006 e foram identificados 
30 casos com sintomas extra-esofágicos relacionadas à asma. As variáveis  consideradas foram: 
sexo, idade, sintomas gastroesofágicos (azia, refluxo ácido e disfagia), o tempo da doença 
do refluxo, o tratamento com inibidores da bomba de prótons, o uso de medicamentos 
específicos, tratamento e a evolução, o número de crises e o grau de esofagite. Os dados 
foram submetidos à análise estatística, comparando os resultados pré e pós-operatórios. 
Resultados: A análise comparativa antes da operação (T1) e seis meses após (T2) mostrou 
redução significativa dos sintomas de azia e refluxo. Além disso, houve diferença significativa 
entre os doentes com crises diárias de asma (T1, versus T2, 45,83% para 16,67%, p=0,0002) 
e crises contínuas (T1, 41,67% versus T2, 8,33%, p=0,0002). Conclusão: A fundoplicatura à 
Nissen por via laparoscópica foi eficaz na melhora dos sintomas que são típicos da doença do 
refluxo e manifestações clínicas da asma, melhorando a qualidade de vida.
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INTRODUCTION
The clinical manifestations that are considered typical symptoms of the gastroesophageal reflux disease (GERD) are mainly heartburn, regurgitation and dysphagia1. Atypical and extra-esophageal symptoms are asthma, 
bronchitis, idiopathic pulmonary fibrosis, hoarseness, subglottic stenosis, granuloma 
of the vocal fold and laryngeal carcinoma and other extra-esophageal manifestations 
such as non-cardiac chest pain, sinusitis, pharyngitis and apnea sleep2. The atypical 
symptoms of reflux disease can occur in up to 74.4% of the patients with GERD3,4.
The upper digestive endoscopy and contrast radiography of the esophagus, 
stomach and duodenum may be useful in the diagnosis of GERD and have been 
an important tool for the detection of esophageal complications. The 24 h-pH 
monitoring plays an important role in the evaluation of patients with extra-esophageal 
manifestations. However, a positive test only confirms the coexistence between 
pathologic gastroesophageal reflux and symptoms, not ensuring a relationship of 
cause and effect2.
Asthma is considered the main extra-esophageal manifestation of GERD. 
Among the drugs used for asthma control, some may favor reflux because they 
relax the smooth muscles of the esophagus and stomach, such as theophylline and 
beta-adrenergic agonists, causing a delay in gastric emptying, which creates a pro-
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reflux effect. The clinical treatment of GERD collaborates 
in controlling symptoms of asthma, with the possibility of 
reducing medication, although without satisfactory changes 
in the respiratory parameters2,4. 
The antireflux surgery has been shown to significantly 
improve respiratory symptoms associated with GERD and 
reduce the need for medications. This fact has a great 
importance since the atypical manifestations require more 
aggressive antisecretory therapy when compared with typical 
GERD symptoms. The association between atypical symptoms 
and GERD is still not so clear and there is some controversy 
about the effectiveness treating these symptoms. Thus, it 
is justified to investigate the prevalence of symptoms and 
control analysis of these symptoms with surgical treatment, 
using laparoscopic fundoplication2.
The aim of this study is to analyze the effectiveness 
of laparoscopic fundoplication in the remission of extra-
esophageal symptoms of asthma in patients with GERD.
METHODS
Were reviewed the medical records of 400 patients 
treated in the Unicamp University Hospital, Campinas, 
SP, Brazil, with confirmed diagnosis of gastroesophageal 
reflux disease, aged over 18 years old, and who underwent 
laparoscopic fundoplication from 1994 and 2006; were 
identified 30 patients with extra-esophageal symptoms 
related to asthma (7,5%).
The classification of asthma used was the recommended 
by the Guidelines of the Brazilian Medical Association and the 
Federal Council of Medicine5. The variables considered were: 
gender, age, gastroesophageal symptoms (heartburn, acid 
reflux and dysphagia), time history of reflux disease, treatment 
with proton pump inhibitor, use of specific medications, 
symptoms, treatment and evolution, number of recurrences, 
degree of esophagitis and data from additional tests.
All patients presented preoperative radiological 
examinations showing gastroesophageal reflux and upper 
digestive endoscopy pre- and postoperative.
Were compared the data from the patients before (Time 
1 – T1) and six months after (Time 2 – T2) the laparoscopic 
surgery, considering the following parameters: the intensity 
of the gastroesophageal symptoms according to the use and 
dosage of the specific medication, the number of asthma 
crisis and degree of esophagitis. The last interview of the 
patients evaluated after surgery was considered the Time 3 
– T3, which happened on average at 37 months follow-up.
The surgical technique employed was the laparoscopic 
Nissen fundoplication (short and flopping)2 performed by the 
same surgeons team.
The asthma crisis were classified as intermittent (none 
or <2/week), mild (3-4/week), moderate (daily) and severe 
(continuous). The degree of esophagitis was obtained by 
upper endoscopy and data were classified, in degrees, by the 
Los Angeles classification.
Data were subjected to statistical analysis, comparing 
the pre- and postoperative findings. For this, was used the 
SAS program (Statistical Analysis System, SAS Institute Inc., 
1996).
To describe the profile of the studied group, according 
to the previously established variables, frequency tables were 
made for categorical variables and arithmetic descriptive 
statistics of the continuous variables. The comparison of 
proportions was performed using the chi-square or Fisher’s 
exact test, when necessary. Continuous variables were 
compared by Student’s t test for independent samples. In all 
cases, was used a significance level of 5% (p<0.05) to reject 
the null hypothesis.
RESULTS
Among the 30 patients included in the study, 17 
(58.62%) had reflux disease for more than five years, while 
29 (96.67%) had heartburn, 21 (70%) had reflux and 15 (50%) 
mild dysphagia. Regarding the treatment during this period, 
16 (53.33%) used H2-receptor antagonist and 24 (80%), 
proton pump inhibitor. Using the Los Angeles classification to 
assess the degree of esophagitis, 10 (33.33%) were in class A, 
five (16.67%) in class B, four (13.33%) in class C, five (16.67%) 
in class D and the remaining six (20%) had no esophagitis.
The comparative analysis between the pre-operative 
evaluation (T1) and six months after surgery (T2) showed a 
significant reduction in symptoms of heartburn, reflux and the 
use of proton pump inhibitors and H2 receptor antagonist. 
On the other hand, the symptom of dysphagia showed a non-
significant reduction (Table 1).
TABLE 1 - Comparative analysis of the variables related to the 
typical symptoms between times 1 and 2
Variables T1 T2   p
Heartburn 25 (96.15%) 5 (19.23%) <0.0001(*)
Reflux 19 (73.08%) 3 (11.54%) <0.0001(*)
Disphagia 13 (50%) 6 (23.08%) 0.0522
Use of proton pump inhibitor 20 (80%) 2 (8%) <0.0001(*)
Use of H2-receptor antagonist 14 (56%) 2 (8%) 0.0013(*)
(*) p<0.05
After six months of surgery (T2), it was observed a 
significant improve in the degree of the esophagitis, using 
the Los Angeles Classification (Table 2).
The preoperative data showed that 27 patients (90%) 
had asthma crisis for over five years, being that 10% had less 
than two asthma crisis per week, 10% had 3-4 per week, 40% 
had daily crises and 40% had continuing crises.
TABLE 2 - Comparison of the degree of esophagitis between 
times 1 and 2
Degree of esophagitis T1 T2 (*)
No esophagitis 2 (15.38%) 2 (15.38%)
A 6 (46.15%) 2 (15.38%)
B 2 (15.38%) 0 (0.00%)
C 2 (15.38%) 1 (7.69|%) 
D 1 (7.69|%) 1 (7.69|%)
(*) p=0.0038 – p<0,05
Comparing T1 and T2, there was a significant difference 
between the patients with daily asthma crises (T1, 45.83% 
versus T2, 16.67%, p=0.0002) and continuous crises (T1, 
41.67% versus T2, 8,33%, p=0.0002). Table 3 shows the data 
of the clinical interview about hospitalization for asthma, 
limitation of physical activity and missed work days, and use 
of mechanical ventilation before surgery (T1) and after the 
surgery (T3). 
TABLE 3 - Comparative analysis of parameters of asthma 
severity
Variable T1 T3   p
Hospitalization for asthma 17 (73.91%) 3 (13.04%) 0.0002(*)
Limitation of physical activity 20 (86.96%) 3 (13.04%) <0.0001(*)
Absence from work 15 (65.22%) 2 (8.70%) 0.0003(*)
Need for mechanical ventilation 7 (30.43%) 1 (4.35%) 0.0143(*)
(*) p<0.05
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Regarding the medication used to control asthma, 
there was no significant difference between T1 and T2 in the 
use of short-acting beta agonist, xanthine, anticholinergics, 
inhaled corticosteroids and long-term beta agonist; 
however, there was a significant reduction in the use of oral 
steroid therapy (Table 4).
Comparing T1 with the last postoperative assessment 
(T3), there was a significant difference in the use of short-
acting beta agonist, xanthine, long-term beta agonist and 
the reduction of oral steroid therapy remained significant 
(Table 5).
Comparing T2 to T3, most parameters showed no 
significant differences, only the symptom of dysphagia 
increased T3 (T2, 23.08% versus T3, 57.69%, p=0.0067), the 
use of short-acting beta agonist was reduced (T2, 78.26% 
versus T3, 47.83%, p= 0.0196) and the use of long-acting 
beta agonists increased (T2, 34.78% versus T3, 78.26%, 
p=0.0039).
TABLE 4 - Comparative analysis of medication related to 
atypical symptoms between times 1 and 2
Variables T1 T2   p
Short-acting beta agonist 21 (91.30%) 18 (78.26%) 0.2568
Anticholinergic 12 (52.17%) 7 (30.43%) 0.1317
Oral corticosteroids 12 (52.17%) 5 (21.74%) 0.0082(*)
Xantine 12 (52.17%) 9 (39.13%) 0.1797
Long-acting beta agonist 9 (39.13%) 8 (39.78%) 0.6547
Inhaled corticosteroids 15 (65.22%) 14 (60.87%) 0.7389
(*)p<0.05
TABLE 5 - Comparative analysis of medication related to 
atypical symptoms between times 1 and 3
Variables T1 T3   p
Short-acting beta agonist 21 (91.30%) 11 (47.83%) 0.0039 (*)
Anticholinergic 12 (52.17%) 5 (21.74%) 0.0348(*)
Oral corticosteroids 12 (52.17%) 3 (13.04%) 0.0027(*)
Xantine 12 (52.17%) 4 (17.39%) 0.0047(*)
Long-acting beta agonist 9 (39.13%) 18 (78.26%) 0.0067(*)
Inhaled corticosteroids 15 (65.22%) 16 (69.57%) 0.7389
    (*) p<0.05
DISCUSSION
The GERD is secondary the reduced efficacy of 
esophageal anti-reflux mechanisms, especially the tone of 
the lower esophageal sphincter, sliding hiatal hernia, slow or 
inadequate elimination of the refluxate, slow gastric emptying 
time, and increased gastric volume1.
The treatment of reflux disease is mainly clinical, with 
the use of antacids and acid blockers. Failure to control 
the symptoms with medication suggests misdiagnosis or 
relatively serious ailment. In this study, 80% of the patients 
were using proton pump inhibitor and 53.33%, the H2 receptor 
antagonists during pre-operatory, without symptomatic 
control. Moreover, the majority of the patients (58.62%) had 
the reflux disease for over five years, a factor that contributes 
to the ineffectiveness of the drug therapy, as it is shown in the 
literature that more than 50% of patients with chronic reflux 
have frequent recurrence of symptoms despite appropriate 
treatment3,6.
Although the aim of the medical and surgical treatment 
is to relieve the symptoms, surgery also generates a 
mechanical solution, while drug therapy is limited to acid 
suppression7.
The laparoscopic antireflux fundoplication allows the 
maintenance of the gastroesophageal junction in intra-
abdominal position and construction of a valve with the 
gastric fundus, re-safely establishing the competence of 
the lower esophageal sphincter through the mechanical 
improvement of its function2,8.
The anti-reflux surgery has been very effective in 
relieving symptoms in 88-95% of patients with good patient 
satisfaction in studies in the short and long term. These 
results include patients with complicated GERD, large hiatal 
hernias, refractory esophagitis and peptic stricture6,8.
This study shows that there was a significant 
improvement in symptoms of heartburn (T1, 96.15% versus 
T2, 19.23%, p<0.0001) and reflux (T1, 73.08% versus T2, 
11.54%, p<0.0001), with no statistical difference between T2 
and T3, showing that the surgery was effective in controlling 
typical symptoms.
Recently, other authors recorded that surgery has been 
proven effective, but there are doubts about the durability of 
the action. Long-term results showed that after 10 years, 92% 
of the patients randomized to the medication continued its 
use and 62% of those who were initially treated with surgery 
returned to use drug therapy8,9,10. In this study, few patients 
maintained use of antacids postoperatively. The use of proton 
pump inhibitors and H2 receptor antagonist decreased (T1, 
80% versus T2, 8%, p<0.0001) and (T1, 56% versus T2, 8%, 
p=0.0013), respectively. Furthermore, was observed no 
significant difference in the use of proton pump inhibitors or 
H2 receptor blockers between times T2 and T3.
Dysphagia is one of the most common side effects of 
laparoscopic antireflux surgery in the immediate postoperative 
period, usually improving the first six weeks after surgery. The 
persistent dysphagia may occur in 2-5% of the patients2,4,11. In 
this study 15 (50%) of the patients already had symptoms in 
the preoperative evaluation, with no significant reduction in 
the postoperative period of approximately six months (T1, 50% 
versus T2, 23.08%, p=0.0522), probably due to esophageal 
dismotility. The fact that the symptom of dysphagia increased 
in T3 (T2, 23.08% versus T3, 57.69%, p=0.0067) was not 
expected.
Most of the patients presented with esophagitis before 
surgery, and six months after 69.23% (p=0.0038) of the 
sample not presenting this complication. In relation to the 
effects of acid-reduction therapy in asthma control, some 
authors reviewed 12 studies and the pooled data showed 
an improvement in asthma symptoms in 69% of patients, 
and 62% reduced bronchodilator use without increased 
exacerbations8,10.
Another group of researchers studied respiratory 
symptoms in GERD patients initially treated with proton 
pump inhibitor and subsequently with anti-reflux surgery and 
found that after six months of treatment with proton pump 
inhibitor, the respiratory symptoms decreased in only 14% of 
the patients and no patient remained asymptomatic during 
this period. After laparoscopic fundoplication, the decrease 
in respiratory symptoms occurred in 86% of the patients 
and 67% remained asymptomatic until the end of the study 
8,9,10,12,13. 
This study showed, between periods T1 and T2, the 
reduction in oral steroid therapy (T1, 52.17% versus T2, 
21.74%, p=0.0082) with a significant difference. Lately, 
there was a decrease in the use of short-acting beta agonist 
(T1, 91.30% versus T3, 47.83%, p=0.0039), xanthine (T1, 
52.17% versus T3,  17.39%; p=0.0047) and the use of oral 
corticosteroids (T1, 52.17% versus T3, 13.04%, p=0.0027), 
as well as an increased use of long-acting beta agonist (T1, 
39.13% versus T3, 78.26%, p=0.0067). These data suggest 
decreased asthma crisis, lower severity of the crisis and higher 
use of such maintenance therapeutic versus treatment of 
crises, which may be interpreted as a clinical improvement 
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of the patient.
Sontag et al. analyzed 62 patients with both GERD and 
asthma, in a randomized study, divided in three types of 
treatments: control group (24 cases), treatment of reflux with 
ranitidine 150 mg three times a day (22 cases) and surgical 
treatment with Nissen fundoplication (16 cases). After a 
2-year follow-up, 75% of surgical patients had improvement 
in nocturnal asthma exacerbations, compared with 9.1% 
and 4.2% of patients on medical therapy and controls, 
respectively14.
Westcott et al. studied 41 patients with documented 
laryngopharyngeal reflux disease and symptoms of 
hoarseness, vocal fatigue, globus, chronic throat clearing, 
chronic cough, and laryngospasm submitted to laparoscopic 
floppy Nissen fundoplication. They concluded that the 
laryngeal symptoms secondary to GERD after fundoplication 
and may take longer to be resolved compared to esophageal 
symptoms, however, a subjective overall response rate of 85% 
positive is possible15.
Koch et al. analyzed the results of partial (Toupet, 
n=50) and total fundoplication (floppy Nissen, n=50) 
in a hundred patients with extraesophageal symptoms 
(cough, asthma, hoarseness, and distortion of taste) in a 
selected cohort of patients with GERD, using a standardized 
symptom questionnaire before surgery and at three and 
12 month follow-up.They concluded that the laparoscopic 
fundoplication is justified for patients with documented 
GERD and atypical symptoms refractory to medical treatment. 
However, the Toupet fundoplication may have a lesser effect 
on asthma16.
In agreement with the literature, was observed a 
significant differences between the patients with daily 
symptoms of asthma (T1, 45.83% versus T2, 16.67%, p= 
0.0002) and persistent symptoms (T1, 41.67% and T2, 8.33%, 
p=0.0002), moreover, this reduction was maintained, since 
there was no significant difference between T2 and T3 
(p=0.2827, p>0.05).
The data analyzed from the clinical interview are 
noteworthy, where prior to surgery, 17 patients (73.91%) 
reported hospitalization for asthma, also with the need 
for mechanical ventilation in seven (30.43%) patients. In 
the postoperative data, only tgree (13.04%, p=0.0002) 
were hospitalized and one (4.35%, p 0.0143) subjected to 
ventilatory support.
As for physical activity, 20 patients (86.96%) reported 
limitations before surgery, and 15 (65.22%) had the need 
to miss work. In the postoperative period, three ( 13.04%, 
p<0.0001) continued to show limitation of physical activity 
and two (8.70%, p=0.0003) had to miss work.
CONCLUSION
The laparoscopic Nissen fundoplication was effective in 
decreasing the symptoms that are typical of reflux disease 
and clinical manifestations of asthma, allowing the reduction 
of the drugs employed during the studied period, and 
improving the quality of life.
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